BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17081648)

  • 21. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2.
    del Amo EM; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2008 Oct; 35(3):161-74. PubMed ID: 18656534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier.
    Hosoya K; Tomi M; Tachikawa M
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1571-87. PubMed ID: 22035231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges and obstacles of ocular pharmacokinetics and drug delivery.
    Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1131-5. PubMed ID: 17097758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical and pharmacological importance of peptide transporters.
    Brandsch M; Knütter I; Bosse-Doenecke E
    J Pharm Pharmacol; 2008 May; 60(5):543-85. PubMed ID: 18416933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal pigment epithelium melanin and ocular toxicity.
    Dayhaw-Barker P
    Int J Toxicol; 2002; 21(6):451-4. PubMed ID: 12537641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine.
    Hosoya K; Makihara A; Tsujikawa Y; Yoneyama D; Mori S; Terasaki T; Akanuma S; Tomi M; Tachikawa M
    J Pharmacol Exp Ther; 2009 Apr; 329(1):87-93. PubMed ID: 19116370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Modeling of Ocular Pharmacokinetics and Adverse Effects.
    Ghemtio L; Xhaard H; Urtti A; Kidron H
    Curr Pharm Des; 2016; 22(46):6928-6934. PubMed ID: 27669964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
    Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
    Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in drug and nutrient transport across the blood-retinal barrier.
    Kubo Y; Akanuma SI; Hosoya KI
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):513-531. PubMed ID: 29719158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transporters--the view from industry.
    Kohl C
    Chem Biodivers; 2009 Nov; 6(11):1988-99. PubMed ID: 19937835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.
    Zolk O; Fromm MF
    Clin Pharmacol Ther; 2011 Jun; 89(6):798-805. PubMed ID: 21471963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diffusion and pharmacokinetics of antibiotics in the ocular globus. Therapeutic implications].
    García E; Mensa J; Martínez JA
    Rev Esp Quimioter; 2001 Dec; 14(4):331-9. PubMed ID: 11856978
    [No Abstract]   [Full Text] [Related]  

  • 33. Designing pregnancy centered medications: drugs which do not cross the human placenta.
    Gedeon C; Koren G
    Placenta; 2006 Aug; 27(8):861-8. PubMed ID: 16313957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular evidence and functional expression of multidrug resistance associated protein (MRP) in rabbit corneal epithelial cells.
    Karla PK; Pal D; Mitra AK
    Exp Eye Res; 2007 Jan; 84(1):53-60. PubMed ID: 17083930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of drug transporters at the blood-brain barrier.
    de Boer AG; van der Sandt IC; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2003; 43():629-56. PubMed ID: 12415123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive insight on ocular pharmacokinetics.
    Agrahari V; Mandal A; Agrahari V; Trinh HM; Joseph M; Ray A; Hadji H; Mitra R; Pal D; Mitra AK
    Drug Deliv Transl Res; 2016 Dec; 6(6):735-754. PubMed ID: 27798766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation.
    Hosoya K; Lee VH; Kim KJ
    Eur J Pharm Biopharm; 2005 Jul; 60(2):227-40. PubMed ID: 15939235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose transport across ocular barriers of the spiny dogfish, Squalus acanthias.
    DiMattio J; Zadunaisky JA
    J Exp Zool; 1982 Feb; 219(2):197-203. PubMed ID: 7061971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery.
    Varma MV; Perumal OP; Panchagnula R
    Curr Opin Chem Biol; 2006 Aug; 10(4):367-73. PubMed ID: 16814593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.